Successful desensitization of enfuvirtide after a first attempt failure.
Machado
Elizabeth S
ES
Passoni
Luis Fernando C
LF
Sidi
Leon Claude
LC
Andrade
Hugo Boechat
HB
De Menezes
Jacqueline A
JA
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D003888:Desensitization, Immunologic / Q000379:methods*; D003875:Drug Eruptions / Q000209:etiology*; D000077560:Enfuvirtide; D005260:Female; D015700:HIV Envelope Protein gp41 / Q000009:adverse effects*; D023581:HIV Fusion Inhibitors / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000009:adverse effects*
D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide